Gastrointestinal Cancers clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
This is a randomized trial of patients with gastrointestinal (GI) cancers treated at University of California, San Francisco (UCSF) who are starting a new line of systemic therapy to evaluate the feasibility of electronic patient reported outcome (ePRO) platform.
San Francisco, California
Our lead scientists for Gastrointestinal Cancers research studies include Wesley A Kidder, MD.